Clinical Trial

Managing Pain and Symptom Burden Caused by Chemotherapy in People With Myeloma or Lymphoma

Active, Not Recruiting Phase 3

Summary

The purpose of this study is to find out whether acupuncture treatments can reduce the need for opioid medication when managing pain caused by chemotherapy. The study will compare the effects of adding acupuncture to usual pain management with those of usual pain management alone, in reducing opioid use by relieving pain. Researchers also want to find out more about the effects of acupuncture treatments on other symptoms caused by cancer treatments and quality of life.

Protocol Amendment History 16 amendments

This ClinicalTrials.gov record has been amended 16 times since 2020-07-01; most recent amendment 2025-10-15.

Status change: Recruiting → Active, Not Recruiting 2023-08-10

Trial Details

NCT Number	NCT04459416
Lead Sponsor	Memorial Sloan Kettering Cancer Center Collaborators: Patient-Centered Outcomes Research Institute, Hackensack Meridian Health
Conditions	Multiple Myeloma, Hodgkin Disease, Non-Hodgkin Lymphoma
Enrollment	299 participants
Start Date	2020-06-30
Primary Completion	2024-07-02 (estimated)
Study Completion	2026-06 (estimated)
Updated on ClinicalTrials.gov	2025-10-20